AstraZeneca Access 360 Co-pay Program

Manufacturer copay assistance · Datroway (J9011) · AstraZeneca

$0 · Maximum benefit $25,000/year · Covers drug cost only — administration billed separately

OPEN
Status verified April 12, 2026 · Source: program site ↗

Program terms

Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.

Assistance type
Copay Assist
Patient pays
$0
Maximum benefit
$25,000/year
What it covers
Covers drug cost only — administration billed separately
Insurance
commercial no medicare no medicaid no government
Datopotamab deruxtecan — co-marketed with AstraZeneca

Medicare or Medicaid patient?

This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.

No foundation fund in our catalog currently matches Datroway — check the full fund board.

What will the patient owe before assistance?

Run a benefits estimate for Datroway — the program's cap applies against the patient share CareCost calculates.

Common questions

Does Datroway have a copay card?

Yes — AstraZeneca Access 360 Co-pay Program from AstraZeneca. $0. Commercial insurance is required; Medicare and Medicaid patients are not eligible.

How much does Datroway cost with the copay card?

$0 Maximum benefit: $25,000/year. Covers drug cost only — administration billed separately

Who is eligible for AstraZeneca Access 360 Co-pay Program?

Accepted insurance: commercial. Not eligible: medicare, medicaid, government.

Patient or caregiver? Your infusion center's financial counselor can enroll you — or call the program at 844-275-2360.